Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
Yun Wang(Shanxi Medical University), Lixin Jiang(Fudan University), Zihan Jiang, Jiapeng Lu(Tongren Hospital), Sharon‐Lise T. Normand(Harvard University), Harlan M. Krumholz(Yale New Haven Hospital), Shuang Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Chao Xing(State Grid Corporation of China (China)), Jing Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xin Zheng(Guangzhou Medical University), Chaoqun Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueke Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Rishi K. Wadhera(Beth Israel Deaconess Medical Center), Qianying Wang(Chinese Academy of Sciences), Yetong Li(Beijing Normal University)
Cited by 78
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
|Circulation|2006|2.1k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
|Journal of the American College of Cardiology|2012|1.6k